Company / Cash per Share
Cytokinetics Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1020.11
FY2025
5-year range
$0.77 / $1020.11
FY2021-FY2025
Trend
+109203.1%
vs FY2024
Sector context
#3 of 205
Health Care
What the data says
Cash per Share changed +109203% YoY in FY2025, a notable deviation from the 9-year average annual change of +12139%.
Based on SEC 10-K filings.
1020.11 in FY2025 with a 5-year CAGR of +287.4%. Ranks 3rd among 205 companies in Health Care.
Improved from $1.19 to $1020.11 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +996.7%
- 5-Year CAGR
- +287.4%
- 10-Year CAGR
- -
Sector benchmark
Top 1% in Health CareTop 1% of 205This company $1020.11 Sector average $72.93
▼
+1298.7% above sector average
Key checks
Key Insights
- In FY2025, cash per share increased 109203.1% year-over-year.
- Ranks #3 out of 205 companies in the Health Care sector.
- Lowest cash per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -3.12 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1020.11 | +109203.1% |
| FY2024 | $0.93 | -21.7% |
| FY2023 | $1.19 | +54.1% |
| FY2022 | $0.77 | -41.8% |
| FY2021 | $1.33 | +13.7% |
| FY2020 | $1.17 | +89.8% |
| FY2019 | $0.62 | -20.3% |
| FY2018 | $0.77 | -66.7% |
| FY2017 | $2.32 | +41.0% |
| FY2016 | $1.65 | +0.1% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026